Key terms
About STTK
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest STTK news
Apr 12
7:00am ET
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
Apr 09
6:16am ET
Strong Buy Rating for Shattuck Labs on Innovative Immunotherapy Pipeline and Leadership
Mar 04
7:06am ET
Shattuck Labs appoints Siegall, Sasser to board of directors
Mar 01
6:57am ET
Buy Rating Affirmed for Shattuck Labs on Promising Clinical Updates and Strong Financial Position
Mar 01
6:57am ET
Buy Rating Justified: Shattuck Labs’ Breakthrough in Cancer Immunotherapy and Strong Financials
Mar 01
6:18am ET
Buy Rating Affirmed for Shattuck Labs on Strong Financials and Promising Clinical Trials
Feb 29
9:46pm ET
Shattuck Labs (STTK) Receives a Buy from TD Cowen
Feb 29
4:25pm ET
Shattuck Labs reports Q4 EPS (41c), consensus (57c)
Feb 14
5:40am ET
Ono enters drug discovery pact, option agreement with Shattuck Labs
Feb 13
9:20am ET
Analysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Shattuck Labs (STTK)
Feb 13
6:24am ET
Shattuck Labs Forms Drug Development Alliance with Ono Pharmaceutical
Feb 13
5:02am ET
3 Best Stocks to Buy Now, 2/13/2024, According to Top Analysts
Feb 12
6:30am ET
Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Molina Healthcare (MOH)
Jan 24
4:33pm ET
Shattuck Labs files to sell 3.1M shares of common stock for holders
No recent press releases are available for STTK
STTK Financials
Key terms
Ad Feedback
STTK Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
STTK Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range